NewsSales Up Sharply At Sativa Wellness But Operational Costs...

Sales Up Sharply At Sativa Wellness But Operational Costs Lead to £4.5m Loss

-

BRITISH CBD firm Sativa Wellness saw annual sales rise by over one-third in an eventful year which saw it undertake a reverse takeover and settle an outstanding court case.

For the year ended December 31, 2020, the company posted revenues of £1,994,000, up from £1,449,000 in 2019, however outstanding commitments and reverse takeover costs saw it record an overall loss of £4.5m for the year.

The company (formerly the Sativa Group) was created following a reverse takeover of StillCanna and is now dual-listed on the Canadian Securities Exchange and Aquis Growth Exchange in London.

Its annual accounts show it reached a settlement with fellow UK firm Dragonfly Biosciences in relation to the delayed completion of a Romanian production facility.

This is now owned by Dragonfly and Sativa’s accounts show it received a cash settlement of £200,000 with company founder Geremy Thomas telling BusinessCann the agreement included additional supply of CBD from the facility to Sativa.

Much Better Shape

In January, Mr Thomas, who owns 30% of the company returned to the board as Executive Chairman and interim CEO.

Mr Thomas told BusinessCann: “The company is in much better shape after I have resumed control. We have new senior management team, a clear set of objectives and will be revealing our new CBD strategy in due course. 

“I am excited to report on our Q1 results in a few weeks time which will show a real uptick in performance”

Sativa Wellness consists of a number of subsidiaries including Goodbody Botanicals and Phytovista Laboratories.

The Covid-19 pandemic impacted the company initially with the closure of its High Street shops however it subsequently pivoted to manufacturing hand-cleansers and testing work.

Last week Sativa announced it has appointed Marc Howells as Chief Executive Officer and Anne Tew as Chief Financial Officer


LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis...

Reakiro – Europe’s Leading CBD And Hemp Brand – Delivers The Complete B2B & B2C Package

IN a time when CBD products are becoming unavoidable in the health, wellness and fitness industries, it is more...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European country to legalise adult-use cannabis have emerged. In an interview on...

Cannabis Is Now A Compelling Opportunity For The Main Tobacco Companies

International cannabis expert, Barbara Pastori, of Prohibition Partners shares her thoughts on why cannabis is a compelling opportunity for...

Oxford Cannabinoid Technologies Holdings Sign Exclusive Worldwide License Agreement With Canopy Growth

Oxford Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (“OCT”) (together, the “Group”), a...

With Global Cannabis Cultivation Capacity Set To Outstrip Demand One Hundredfold – What Happened To The ‘Green’ Rush?

CANNABIS investors need to be wary when it comes to cultivation, says Oliver Zugel, Founder and CEO FoliuMed Holdings. Where...

Must read

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European...

You might also likeRELATED
Recommended to you